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Background: Age-	related	 immune	 deficiencies	 are	 thought	 to	 be	 responsible	 for	
increased	 susceptibility	 to	 infection	 in	older	 adults,	with	 alterations	 in	 lymphocyte	






Methods: B	 cells	were	 isolated	 from	healthy	 individuals,	 in	 younger	 (30–	38	 years)	
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1  |  INTRODUC TION
There is no doubt that ageing is associated with multiple changes 




parallel,	a	state	of	chronic,	 low	 level	 inflammation	 (inflammageing)	
is	 observed	 in	 the	 elderly	 (Franceschi	 et	 al.,	 2000;	 Montecino-	
Rodriguez	et	al.,	2013).	Primary	dysfunctions	in	human	T	and	B	cells	
contribute	 to	 these	age-	related	aberrations,	 in	addition	 to	 the	 rel-
ative	 loss	 of	 cells	 (Aspinall	&	Andrew,	 2000;	Aw	 et	 al.,	 2007;	 Fali	
et	 al.,	 2018;	Goronzy	 et	 al.,	 2015;	McElhaney	 et	 al.,	 2020;	Quinn	
et	 al.,	 2018;	 Sansoni	 et	 al.,	 1993;	Wagner	 et	 al.,	 2018).	 There	 is	 a	
general	decline	of	T-	cell	functions,	exemplified	by	weaker	activation	
of	T	cells	resulting	in	poor	proliferative	capacity	(Salam	et	al.,	2013;	
Wagner	 et	 al.,	 2018).	 Effector	 functions	of	CD4+ T cells including 
antigen	recognition	(Goronzy	et	al.,	2015)	and	killing	capacity	of	CD8	
T	cells	are	reduced	(McElhaney	et	al.,	2020;	Quinn	et	al.,	2018)	and	
thought to be responsible for an increased susceptibility to infection 
in	older	 adults	 (Aw	et	 al.,	 2007).	Additionally,	 it	 is	 also	well	 docu-
mented	that	human	(and	mice)	T-	cell	lymphopoiesis	is	reduced	with	
ageing	(Aspinall	&	Andrew,	2000;	Fali	et	al.,	2018;	Sun	et	al.,	2012),	





are	 reduced,	 as	 well	 as	 vaccine	 responses,	 with	 change	 in	 reper-
toire	and	 telomere	 length	 (Bulati	et	al.,	2011;	Cancro	et	al.,	2009;	
Crooke	et	al.,	2019;	Guerrettaz	et	al.,	2008;	Lin	et	al.,	2016;	Martin	
et	al.,	2015).	Furthermore,	studies	suggested	that	ageing	affects	B-	






response and tolerance is therefore compromised with age. This re-





In	vivo,	 the	B-	cell	 response	 to	an	antigenic	challenge	 includes	
two	 waves	 of	 differentiation.	 An	 early	 response	 generates	 pro-
liferation	 and	 the	 differentiation	 of	memory	B	 cells	 that	 produce	
germline-	encoded	or	sparsely	mutated	antibodies,	as	well	as	early	
plasmablasts	 (EPBs)	 that	 are	 short-	lived	 (Sabouri	 et	 al.,	 2016).	
Previous	reports	have	shown	that	total	CD19+	B	cells	from	elderly	
donors	 (>65	 years)	 are	 less	 able	 to	 differentiate	 after	 stimulation	
in	vitro	with	polyclonal	activators	 (CpG	or	SAC	+	IL-	2)	that	gener-
ate	 short-	lived	 plasmablasts	 in	 the	 absence	 of	 T-	cell	 help	 (Frasca	
et	 al.,	 2016;	 Shi	 et	 al.,	 2005).	 In	 a	 second	phase,	B	 cells	 undergo	
further	 expansion	 and	 affinity	maturation	within	 a	 germinal	 cen-
tre	prior	to	terminal	differentiation	into	PC,	but	are	dependent	on	
survival	factors	to	become	long-	lived	PCs.	In	vitro	assays	were	de-
signed	 to	 study	 B-	cell	 differentiation	 into	 PC	 both	 quantitatively	
and	qualitatively	(Cocco	et	al.,	2012;	Shrimpton	et	al.,	2020).	These	
assays	can	use	a	T-	cell-	dependent	 (TD)	or	T-	cell-	independent	 (TI)	









of	 B	 cell	 to	 differentiate	 towards	 a	 full	 PC	 phenotype,	 comparing	




agonist,	 in	 combination	with	 BCR	 stimulation	 (Cocco	 et	 al.,	 2012;	
Shrimpton	 et	 al.,	 2020).	Generated	PC	numbers,	 their	 phenotype,	
secretary	capability	and	gene	expression	profiles	were	compared.
2  |  METHODS
2.1  |  Blood samples
Ethical	 approval	 for	 this	 study	 was	 granted	 by	 the	 Leeds	 East	




donor	 details	 are	 provided	 in	 Table	 S1.	 Peripheral	 blood	 was	 ob-
tained from healthy donors after informed consent.
2.2  |  In vitro B- cell differentiation assays
Mononuclear	 cells	 were	 isolated	 from	 EDTA	 blood,	 by	 density	
centrifugation	 followed	by	negative	 selection	with	a	human	B-	cell	
isolation	kit	 (Miltenyi	Biotec).	 Isolated	B	cells	were	cultured	 in	24-	




Shrimpton	 et	 al.,	 2020),	 for	 both	 TI	 and	 TD	 stimuli.	 B	 cells	 were	

















Cells	were	 counted	 at	 each	 step	 of	 the	 culture,	 and	 all	 assays	
were	normalized	for	cell	numbers	at	days	6	and	13.	Final	results	are	
presented	to	reflect	output	generated	from	1	million	live	B	cells	at	
day 0 for all donors with different proportions of dead cells. Note 
that	between	day	6	and	day	13,	a	large	proportion	of	dead	cells	have	
transformed into apoptotic bodies and small debris and as such are 
no longer counted as a ‘cellular’ event.
2.3  |  Flow cytometric analysis
Cells	 were	 analysed	 using	 seven-	colour	 direct	 immunofluores-











lated	using	CountBright	 beads	 (25,000	beads/panel;	 Invitrogen).	





strategy	 to	 define	 circulating	 naïve/memory	 from	B-	reg	 and	 EPB,	
and	expression	of	surface	Ig	is	described	in	Figure	S2.
2.4  |  viSNE and SPADE analysis
viSNE	 (visualization	of	 t-	distributed	stochastic	neighbourhood	em-
bedding;	https://www.cytob	ank.org/;	Amir	el	al.,	2013)	maps	were	
generated	 to	 visualize	 expression	 levels	 of	 CD24,	 CD27,	 CD38,	
CD138,	 and	 IgD.	Analysis	was	 performed	 using	 the	 default	 t-	SNE	
parameters.	 Clustering	 analysis	 of	 the	 viSNE	 output	 was	 then	
performed	 using	 SPADE	 (Spanning-	tree	 Progression	 Analysis	 of	
Density-	normalized	 Events;	 https://www.cytob	ank.org/).	 Clusters	
of nodes were then labelled manually according to cell phenotype.
2.5  |  Total IgM/A/G secretion




2.6  |  Gene expression
Total	RNA	was	extracted	using	the	Direct-	Zol™	RNA	MiniPrep	(Zymo	
Research).	 Complementary	 DNA	 (cDNA)	 was	 reverse-	transcribed	
from	 total	 RNA	 by	 High-	Capacity	 cDNA	 Reverse	 Transcription	
Kit	 (Applied	 Biosystems).	 Gene	 expression	 was	 quantified	 using	
TaqMan®	 assays	 for	 BCL-	xL	 (BCL2L1;	 Hs00236329_m1),	 BCL2 
(Hs00608023_m1),	 BAX	 (Hs00180269_m1),	 BAD	 (Hs00188930_
m1),	 MCL1	 (Hs01050896_m1),	 XBP1	 (Hs00231936_m1),	 AICDA 
(Hs00757808_m1),	 BLIMP-	1	 (PRDM1;	 Hs00153357_m1)	 and	
AIOLOS	(IKZF3;	Hs00232635_m1)	according	to	the	manufacturer's	
instructions	 (Applied	Biosystems)	 and	 normalized	 using	UBC gene 
(Hs00824723_m1)	as	housekeeping.








3.1  |  Comparison of TD and TI differentiation 
pathways
We	 first	 directly	 compared	 outcomes	 of	 the	 differentiation	models	
(TD	or	TI).	Both	differentiation	assays	were	performed	in	15	individu-
als.	Throughout	both	assays,	cells	moved	from	one	phenotypic	subset	



























extensive	 CD38	 expression	 at	 an	 significantly	 increased	 frequency,	
paired	with	increased	CD27	levels/frequency	and	higher	expression/
frequency	for	CD138,	while	decreased	levels/frequency	of	CD24	and	





tribution of the populations across the subset segments was relatively 





with	 TI	 differentiation	 at	 day	 13	 (Figure	 2c;	 MWU,	 n	 =	 15,	 both	
p	<	0.010).	In	contrast,	levels	of	IgG	secreted	were	higher	during	TI	
differentiation at day 6 (p	=	0.00),	but	similar	at	day	13.
We	therefore	observed	differences	in	the	final	results	of	the	differ-
entiation assay with a clear higher live plasma cell number generated 
by	TD	compared	with	TI.	A	faster	progression	through	differentiation	
was	observed	in	the	TI	assay,	with	the	presence	of	more	cells	 in	the	







an earlier and more effective proliferation phase compared with TD 
(63-	fold	increase).	CD24	expression	undergoes	continuous	expression	




profile being grouped in subsets (region: 
naïve,	memory,	EPB,	early	plasmablasts;	
LPB,	late	plasmablasts;	PC,	plasma	cells)	
based on manual annotation of the 
phenotype.	Organization	of	data	displayed	
for TD/TI differentiation at 3 time points 
(days	0,	6	and	13)	and	colour-	coded	
scale	for	low	(blue)	to	high	(red)	levels	





















progression to late differentiation stages in the TI assay as manifested 
by	more	pronounced	gain	or	loss	of	all	marker's	expression	at	day	6,	
while being more similar at day 13.
We	also	compared	male	(n	=	7)	and	females	(n	=	8)	and	observed	
no	 significant	 differences	 in	 circulating	 subset	 frequency,	 marker	
levels	of	expression,	%	of	+	cells,	Ig	production	and	gene	expression	




3.2  |  Age- related differences in circulating B cells
We	then	analysed	circulating	B-	cell	phenotype	comparing	age	groups	
(younger n	=	8,	and	older	donors,	n	=	7).	Using	a	classic	flow	cytometry	
manual	gating	analysis,	 subsets	defining	naïve	 (CD24+ CD27−	CD38−	
CD138−	IgD+),	memory	(CD24low CD27+ CD38low CD138−	IgD−),	B-	reg	
(CD24high CD27−	CD38high CD138−	 IgD+)	 or	 EPB	 (CD24−	CD27+ CD3






Using	 viSNE	analysis	 and	SPADE	 trees	 (Figure	3,	 day	0	panels	
a	 and	 b,	 representative	 example	 from	1	 donor	 of	 each	 age	 group	
for	both	assays),	higher	levels	of	expression	for	CD38,	CD138,	IgD	
and	 IgM	but	 lower	CD24	 and	 IgA	were	 observed	 in	 older	 donors	
(arrows),	 also	 reflected	 in	 significant	differences	 in	percentages	of	






















at days 6 and 13. p-	Value	for	the	overall	
results between two differentiation assays 
in	(a)	and	(b)	was	calculated	by	ANOVA	
as indicated by the top bar. Comparison 
of the 2 assays at individual time points 
(all	3	panels)	was	tested	by	MWU,	and	
significance	is	indicated	by	symbol	next	
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2-	fold	more	 numerous	 in	 older	 donors	 in	 TI	 differentiation	 (mean	
1	×	105	 live	 cells)	 than	 in	 younger	 ones	 (6	×	104,)	 but	more	 equal	
in	TD	differentiation	(mean	7	×	105 in older donors compared with 
7	×	105	in	younger	ones).
We	 cannot	 fully	 exclude	 that	 the	 initial	 number	 of	memory	 B	
cells present in the blood can influence the outcome of the assays. 
There	were	 less	memory	cells	 in	older	 individuals,	but	this	did	not	
seem	 to	 affect	 the	 TD	 assay	 (Figure	 4;	 bottom	 left	 corner),	while	
it	had	a	clear	positive	effect	on	the	TI	assay,	with	highly	significant	




expected	 pattern.	 At	 day	 13,	 very	 limited	 differences	 were	 ob-
served	 (data	shown	 in	Figure	S6).	Focussing	on	day	6	and	only	on	
age-	related	differences,	CD27	mirrors	the	pattern	of	CD38	but	with	






similar in TD but lower in TI for older donors (both day 6 and day 
13).	 CD24	 and	 IgD	 expressions	were	 both	 lost	 quickly	 (almost	 no	
positive	cells	in	either	assays	by	day	6;	no	significant	change),	while	
at	the	levels	of	expression,	both	markers	were	lost	more	profoundly	
in older donors reaching darker green/blue levels but still orange/
light green in younger ones.






assays with no difference between younger and older donors.
3.4  |  Gene expression of survival and 
transcriptional regulators during differentiations
As	we	 observed	 differences	 both	 in	 expansion	 and	 in	 survival,	 as	
well	 as	 depth	 of	 differentiation,	 9	 genes	were	 chosen	 to	 indicate	
survival/cell death signals during differentiation: BCL2,	BAX,	BAD,	
BCL2L1 (coding for	BCL-	xL)	and	MCL1,	as	well	as	regulator	of	B-	cell	








indeed	 limited,	although	we	observed	a	small	 reduction	 in	expres-




Calame,	 2005;	 Vikstrom	 et	 al.,	 2016)	with	 a	 pronounced	 increase	
(both	 day	 6	 and	 day	 13)	 for	 BCL2L1/BCL-	xL,	 XBP- 1 and PRDM1/
BLIMP1	or	 decrease	 for	BCL2 and IKZF3/Aiolos,	while	AICDA dis-
played only a transient increase. BAD and BAX	expression	remained	
unchanged	 (Figure	 5,	 n	 =	 5	 per	 age	 group,	 ANOVA,	 top	 bars).	
Although	PRDM1/BLIMP1	 increased	 in	 response	 to	 both	 types	 of	
stimuli,	the	levels	at	day	13	dropped	significantly	in	cells	undergoing	








when	 induced	by	TI	 differentiation,	while	 not	observed	under	TD	
differentiation.
Of	note,	a	gender	analysis	of	 the	same	data	showed	no	signif-
icant	 difference	 in	 gene	 expression	 between	 males	 and	 females	
(Figure	S7),	with	trends	for	lower	BCL2 and MCL1 and IKZF3/Aiolos	
in females at day 0.
4  |  DISCUSSION
Altogether,	 our	 data	 showed	 that	 TD	 differentiation	 and	 TI	 dif-
ferentiation	of	B	cells	 follow	similar	patterns	 in	 terms	of	pheno-
typic	 change	 and	 gene	 expression,	 although	 it	 happened	 faster	
during	TI,	but	generated	more	PC	in	TD.	Age	affected	circulating	
B-	cell	 subsets	 as	 expected,	 and	gene	expression	 results	 showed	







The	 blood	 composition	 of	 circulating	 B-	cell	 subsets	 has	 been	
shown	 to	change	with	age	affecting	naïve	and	memory	B	cells,	 as	
well	 as	 B-	reg,	 but	 not	 the	 frequency	 of	 EPB	 (Chong	 et	 al.,	 2005;	
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(a)
(b)
    |  9 of 13XIE Et al.
Duggal	et	al.,	2013;	Ponchel	et	al.,	2015;	Shi	et	al.,	2005).	Our	data	
recapitulated	 these	 observations.	 Apoptosis	 is	 involved	 in	 several	
age-	related	 process	 including	 T-	cell	 immunosenescence	 (Ginaldi	
et	 al.,	 2004;	 Longo	 et	 al.,	 2005).	 Despite	 the	 possible	 differential	
gene	 expression	 contribution	 from	B-	cell	 subsets	 (naïve/memory),	
age	appears	to	affect	anti-	apoptotic	molecule	expression	BCL2 and 
MCL1 (but not BCL- xL)	but	not	 the	pro-	apoptotic	 factors	 (BAX and 
BAD).	 Older	 donors	 have	more	 naïve	 cells	 but	 express	 less	BCL2,	
which	 is	 further	 reduced	 during	 differentiation,	 suggesting	 a	 true	
age-	related	 change.	MCL1	 expression	 remains	 lower	 in	 older	 indi-
viduals,	which	also	suggests	a	true	age-	related	difference.	MCL1	has	
multiple	 roles	 in	 T-	cell-	dependent	 B-	cell	 maturation	 (Peperzak	
et	al.,	2013;	I.	Vikstrom	et	al.,	2010).	As	such,	its	expression	appears	
to	 raise	 continuously	 in	 TD	 (notably	 in	 younger	 donors)	 but	 is	 re-
duced	 in	TI	 (and	 in	 older	 donors).	 These	 suggest	 a	 particular	 age-	
related	 change	 in	 MCL1	 activity	 that	 needs	 further	 exploration.	
BCL2L1	expression	was	shown	to	provide	alternative	B-	cell	survival	
signals	to	PCs	(Amanna	et	al.,	2003).	The	lower	expression	of	BCL2L1 
in older donors may therefore also contribute to the difference in 
PC	numbers.	Short-	lived	PB	at	day	6	may	have	a	better	capacity	for	
developing	 long-	lived	PCs	 in	 aged	donors	particularly	 in	TI,	which	
was	also	observed	in	the	bone	marrow	(Pritz	et	al.,	2015).	However,	
these	changes	are	modest	and	may	not	be	sufficient	to	explain	the	
age-	related	 higher	 live	 cell	 numbers,	 suggesting	 that	 other	 ageing	
mechanisms	may	contribute	to	cell	viability,	as	observed	in	lympho-
mas	(Adams	et	al.,	2018;	Agarwal	&	Naresh,	2002).
Certain	 markers	 of	 B-	cell	 differentiation	 subsets	 were	 previ-
ously	 associated	with	 age	 (CD38-	 and	 CD24-	positive	 cells)	 (Buffa	
et	 al.,	 2013;	Chong	 et	 al.,	 2005).	Our	 data	 support	 these	 findings	
but	 also	 add	 information	 about	 levels	 of	 expression	 showing	 age-	
associated difference for all markers. These suggest that the func-
tion	associated	with	such	molecules	may	indeed	alter	the	way	B	cells	
respond to stimuli and differentiate in ageing.
The	in	vitro	assays	used	activate	all	B	cells	both	from	the	naïve	
and	 from	 the	memory	 subsets,	 then	push	 their	 differentiation	 to-
wards	the	EPB	and	then	LPB	and	PC	subsets.	Analysing	data	with	
respect	to	age	showed	that	in	the	presence	of	T-	cell	help,	older	do-
nors displayed a clear effect on the speed of progression from the 








F I G U R E  5 Expression	profile	of	gene	associated	with	differentiation	and	survival/apoptosis.	Gene	expression	changes	(median,	IQR)	
during	differentiation	assays	between	age	groups	at	different	time	points,	quantified	by	TaqMan	qPCR	(n	=	5	for	each	group).	Overall	
changes	between	two	groups	were	tested	by	ANOVA	(top	bar).	Individual	time	point	differences	were	tested	by	MWU.	○,	younger	donors;	●,	
older donors. p-	Values:	#p	<	0.100;	*p	<	0.050;	**p	<	0.010,	***p	<	0.001;	and	****p = 0.0001
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naïve	subset	into	EPB	(larger	nodes)	and	LPB	(more	nodes)	but	not	
from	the	memory	subset	 (similar	 loss	of	sizeable	nodes).	This	find-
ing is clearly important but could only be detected using novel flow 









Despite the fact that these assays cannot fully reproduce 
microenvironmental	 factors	 in	 the	 bone	 marrow,	 a	 comparison	
of	 gene	 expression	 profiles	 between	 in	 vitro-	derived	 day	 13	PC	
and	 ex	 vivo	 bone	 marrow	 PC	 confirmed	 a	 high	 degree	 of	 con-
cordance	and	no	change	in	the	core	gene	expression	programme	




tion to secrete Igs (XBP- 1 and IKZF3/Aiolos	[Iwakoshi	et	al.,	2003;	
Schmitt	 et	 al.,	 2002]);	 and	 Ig-	class	 switching	 and	hypermutation	
(AICDA	 [Di	Noia	 &	Neuberger,	 2007]).	PRDM1 was more upreg-
ulated	at	day	6	 in	 the	aged	donors	 (both	assays),	 in	 line	with	 an	
accelerated	execution	of	the	early	differentiation.	XPB- 1 was up-
regulated,	however,	with	 limited	difference	between	age	groups,	
in	 line	 with	 the	 acquisition	 of	 the	 secretory	 capability	 at	 day	 6	
(Cenci	&	Sitia,	2007),	and	increased	secretion	at	day	13,	although	
additional	 age-	related	 changes	 in	 metabolic	 fitness	 (associated	
with	mTOR)	may	 also	 influence	 a	B-	cell's	 ability	 to	 secrete	 anti-
bodies	(Stallone	et	al.,	2019;	Tellier	&	Nutt,	2019).
Altogether,	the	use	of	these	assays	allowed	us	to	quantify	the	
intrinsic	 capacity	 of	 B	 cells	 to	 differentiate	 into	 PC	 in	 the	 pres-
ence	 of	 T-	cell	 help	 directly	 compared	 with	 an	 alternative	 using	
TLR	 stimulation.	 Looking	 into	 the	 age-	related	 changes,	 our	 data	
showed	that	B	cells	have	 limited	 intrinsic	quantitative	difference	








were	 observed	 with	 increased	 early	 proliferation	 (200-	fold	 in	
older	 donors,	 compared	with	 73-	fold	 in	 younger	 ones),	 suggest-
ing	a	better	proliferative	capacity	of	older	B	cells,	associated	with	
higher	number	of	PC	generated	at	day	13	(although	not	significant	
in	 this	 small	group).	Again,	 this	was	associated	with	a	 faster	and	






says combined with novel methods to analyse flow cytometry data 
allowed an evaluation of the impact of ageing on the generation 
of	 fully	mature	 PC	with	 or	without	 T-	cell	 help.	Our	 results	 sug-
gest	 that	 B	 cells	 from	older	 donors	 (who	 have	 no	 health	 issues)	
remain	responsive	to	antigenic	challenge	in	the	context	of	in	vitro	
provision	 of	 adequate	 T-	cell	 help/cytokines,	 while	 responding	





seen in older females compared with males (notably as observed in 
the	COVID-	19	pandemic)	(Gadi	et	al.,	2020;	Klein	&	Flanagan,	2016).	
Moreover,	 a	 particular	 subset	 of	memory	B	 cells	 (double	 negative	
IgD−	CD27−),	which	 are	 thought	 to	be	 responsible	 for	 the	produc-
tion	of	autoantibodies	(Claes	et	al.,	2016;	Jacobi	et	al.,	2008;	Moura	
et	al.,	2017),	 is	 increased	in	elderlies	(Frasca	et	al.,	2019)	(although	
no	difference	was	observed	 in	our	 group	of	donors),	 as	well	 as	 in	
patients with autoimmunity. It will therefore be of interest in the 
future,	to	assess	whether	our	 in	vitro	differentiation	models	could	
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